Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Total Assets (Quarterly): 135.49M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 135.49M |
| March 31, 2024 | 143.82M |
| December 31, 2023 | 143.89M |
| September 30, 2023 | 157.19M |
| June 30, 2023 | 246.42M |
| March 31, 2023 | 362.42M |
| December 31, 2022 | 401.07M |
| Date | Value |
|---|---|
| September 30, 2022 | 437.12M |
| June 30, 2022 | 429.34M |
| March 31, 2022 | 434.20M |
| December 31, 2021 | 414.13M |
| September 30, 2021 | 448.29M |
| June 30, 2021 | 128.42M |
| December 31, 2020 | 431.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
128.42M
Minimum
Jun 2021
448.29M
Maximum
Sep 2021
308.06M
Average
381.74M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Dentsply Sirona Inc | 6.626B |
| Ligand Pharmaceuticals Inc | 954.87M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 107.68M |
| Shareholders Equity (Quarterly) | 27.81M |
| Debt to Equity Ratio | 1.474 |
| Current Ratio | 0.2611 |
| Net Debt Paydown Yield | -1.55% |